Effect of VEGF-targeted antisense gene therapy on retinoblastoma cell line SO-RB50 in vitro and in vivo

AIM: To evaluate the possibility of generation 4 polyamidoamine (G4PAMAM) dendrimers acting as the delivery system of vascular endothelial growth factor (VEGF) antisense oligodeoxynucleotides (VEGFASODN), and to investigate the anti-tumor effect of G4PAMAM/VEGFASODN complex on the cultured cells and...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Xin, Guo-Hong, Zhao, Xin-Han, Liu, Dong, Gong, Qiang, Hou, Lei, Li, Jing-Yun, Pan, Bo-Rong, Li, Xu, Cheng, Ya-Jie
Formato: Artigo
Lenguaje:Inglês
Publicado: International Journal of Ophthalmology Press 2012
Materias:
Basic Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3428538/
https://ncbi.nlm.nih.gov/pubmed/22937502
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3980/j.issn.2222-3959.2012.04.07
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares